Venus Concept Receives FDA 510(k) Clearance of Venus BlissMAX
Venus Concept Inc announces it has received 510(k) clearance from the US Food and Drug Administration to market the Venus BlissMAX device in the United States.
Venus Concept Inc announces it has received 510(k) clearance from the US Food and Drug Administration to market the Venus BlissMAX device in the United States.
Older women undergoing breast reconstruction after mastectomy face slightly higher risks of complications but report better psychological well-being despite lower satisfaction with breast appearance, highlighting the need to weigh age-related risks and benefits when considering surgery.